These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27692547)

  • 21. [Piperazine-derivatives. II. Effect of piperazine-derivatives].
    Lányi K; Erdélyi I; Institoris E; Tardos L; Szabó Z
    Arzneimittelforschung; 1968 Nov; 18(11):1431-5. PubMed ID: 5755908
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and preliminary evaluation of pharmacological properties of some piperazine derivatives of xanthone.
    Szkaradek N; Rapacz A; Pytka K; Filipek B; Siwek A; Cegła M; Marona H
    Bioorg Med Chem; 2013 Jan; 21(2):514-22. PubMed ID: 23245804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and cardiovascular activity of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3- piperazinopropyl)-3,7-dihydro-1H-purine-2,6-diones.
    Chłoń-Rzepa G; Pawłowski M; Zygmunt M; Filipek B; Maciag D
    Pol J Pharmacol; 2004; 56(6):755-66. PubMed ID: 15662088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.
    Handzlik J; Bojarski AJ; Satała G; Kubacka M; Sadek B; Ashoor A; Siwek A; Więcek M; Kucwaj K; Filipek B; Kieć-Kononowicz K
    Eur J Med Chem; 2014 May; 78():324-39. PubMed ID: 24691057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, in vitro and in vivo pharmacological evaluation of serotoninergic ligands containing an isonicotinic nucleus.
    Fiorino F; Ciano A; Magli E; Severino B; Corvino A; Perissutti E; Frecentese F; Di Vaio P; Izzo AA; Capasso R; Massarelli P; Nencini C; Rossi I; Kędzierska E; Orzelska-Gòrka J; Bielenica A; Santagada V; Caliendo G
    Eur J Med Chem; 2016 Mar; 110():133-50. PubMed ID: 26820556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-nitrophenyl) cyclohexanecarboxamide: a novel pre- and postsynaptic 5-hydroxytryptamine(1A) receptor antagonist active on the lower urinary tract.
    Leonardi A; Guarneri L; Poggesi E; Angelico P; Velasco C; Cilia A; Testa R
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1027-37. PubMed ID: 11714892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nitric oxide/soluble cyclic guanylase/cyclic guanosine monophosphate pathway is involved in the cardiovascular effects of a novel α1- and β-adrenoceptor antagonist.
    Kubacka M; Mogilski S; Bednarski M; Raźny K; Sapa J; Waszkielewicz AM; Marona H; Filipek B
    Pharmacology; 2014; 94(5-6):287-95. PubMed ID: 25531925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and QSAR studies on hypotensive 1-[3-(4-substituted phenylthio) propyl]-4-(substituted phenyl) piperazines.
    Saxena AK; Rao J; Chakrabarty R; Saxena M; Srimal RC
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1708-12. PubMed ID: 17234413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of pharmacological properties of some new xanthone derivatives with piperazine moiety.
    Waszkielewicz AM; Gunia A; Szkaradek N; Pytka K; Siwek A; Satała G; Bojarski AJ; Szneler E; Marona H
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4419-23. PubMed ID: 23787101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HBK-14 and HBK-15 Do Not Influence Blood Pressure, Lipid Profile, Glucose Level, or Liver Enzymes Activity after Chronic Treatment in Rats.
    Pytka K; Głuch-Lutwin M; Knutelska J; Jakubczyk M; Waszkielewicz A; Kotańska M
    PLoS One; 2016; 11(10):e0165495. PubMed ID: 27788267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New 3-[4-(2,3-dihydro-14-benzodioxin-5-yl)piperazin-1-yl]-1-(5-substituted benzo[b]thiophen-3-yl)propanol derivatives with dual action at 5-HT(1A) serotonin receptors and serotonin transporter as a new class of antidepressants.
    Silanes SP; Orús L; Oficialdegui AM; Martínez Esparza J; Lasheras B; Del Río J; Monge A
    Pharmazie; 2004 Jul; 59(7):499-501. PubMed ID: 15296084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and evaluation of activity and pharmacokinetic profile of new derivatives of xanthone and piperazine in the central nervous system.
    Żelaszczyk D; Jakubczyk M; Pytka K; Rapacz A; Walczak M; Janiszewska P; Pańczyk K; Żmudzki P; Słoczyńska K; Marona H; Waszkielewicz AM
    Bioorg Med Chem Lett; 2019 Nov; 29(21):126679. PubMed ID: 31537425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.
    Sallinen J; Holappa J; Koivisto A; Kuokkanen K; Chapman H; Lehtimäki J; Piepponen P; Mijatovic J; Tanila H; Virtanen R; Sirviö J; Haapalinna A
    Basic Clin Pharmacol Toxicol; 2013 Oct; 113(4):239-49. PubMed ID: 23718812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin.
    Handzlik J; Maciag D; Kubacka M; Mogilski S; Filipek B; Stadnicka K; Kieć-Kononowicz K
    Bioorg Med Chem; 2008 Jun; 16(11):5982-98. PubMed ID: 18490167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and pharmacological evaluation of new N-phenylpiperazine derivatives designed as homologues of the antipsychotic lead compound LASSBio-579.
    Pompeu TE; Alves FR; Figueiredo CD; Antonio CB; Herzfeldt V; Moura BC; Rates SM; Barreiro EJ; Fraga CA; Noël F
    Eur J Med Chem; 2013 Aug; 66():122-34. PubMed ID: 23792350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and central nervous system depressant activity of new piperazine and related derivatives. 3.
    Petigara RB; Deliwala CV; Mandrekar SS; Dadkar NK; Sheth UK
    J Med Chem; 1969 Sep; 12(5):865-70. PubMed ID: 5812201
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis and in vitro pharmacological evaluation of novel 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands.
    Fiorino F; Magli E; Severino B; Corvino A; Ciano A; Perissutti E; Frecentese F; Massarelli P; Nencini C; Santagada V; Caliendo G
    Arch Pharm (Weinheim); 2014 Oct; 347(10):698-706. PubMed ID: 25113046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1'4-Bis(2-indol-3ylethyl)piperazines.
    Archibald JL; Freed ME
    J Med Chem; 1974 Jul; 17(7):745-7. PubMed ID: 4836405
    [No Abstract]   [Full Text] [Related]  

  • 40. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
    Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
    J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.